C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 8.35 USD 0.6% Market Closed
Market Cap: 67.3m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note

Cryo-Cell International Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cryo-Cell International Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
Cryo-Cell International Inc
AMEX:CCEL
Accrued Liabilities
$3.1m
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
10%
DaVita Inc
NYSE:DVA
Accrued Liabilities
$1.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Quest Diagnostics Inc
NYSE:DGX
Accrued Liabilities
$176m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Accrued Liabilities
$21.9B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Cigna Corp
NYSE:CI
Accrued Liabilities
$8.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accrued Liabilities
$941.8m
CAGR 3-Years
-16%
CAGR 5-Years
-2%
CAGR 10-Years
10%
No Stocks Found

Cryo-Cell International Inc
Glance View

Market Cap
67.3m USD
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

CCEL Intrinsic Value
5.83 USD
Overvaluation 30%
Intrinsic Value
Price
C

See Also

What is Cryo-Cell International Inc's Accrued Liabilities?
Accrued Liabilities
3.1m USD

Based on the financial report for Aug 31, 2024, Cryo-Cell International Inc's Accrued Liabilities amounts to 3.1m USD.

What is Cryo-Cell International Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
10%

Over the last year, the Accrued Liabilities growth was 54%. The average annual Accrued Liabilities growth rates for Cryo-Cell International Inc have been 16% over the past three years , 17% over the past five years , and 10% over the past ten years .

Back to Top